| Literature DB >> 35456200 |
Na Zhou1, Gabriel Fortin2, Maria Balice1, Oksana Kovalska1, Pascal Cristofini1, Francois Ledru1, Warner M Mampuya2, Marie-Christine Iliou1.
Abstract
INTRODUCTION: Surgically treated acute type A aortic dissection (ATAAD) patients are often restricted from physical exercise due to a lack of knowledge about safe blood pressure (BP) ranges. The aim of this study was to describe the evolution of early postoperative cardiac rehabilitation (CR) for patients with ATAAD.Entities:
Keywords: blood pressure; cardiac rehabilitation; exercise training; shear stresses; type A acute aortic dissection
Year: 2022 PMID: 35456200 PMCID: PMC9025085 DOI: 10.3390/jcm11082107
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Baseline characteristics.
| Before CR ( | |
|---|---|
| Age (years) | 62.2 ± 12.7 |
| Gender (Male) | 57 (78.1%) |
| Height (cm) | 172.9 ± 10.1 |
| Body weight (kg) | 71.7 ± 17.8 |
| BMI (kg/m2) | 23.9± 4.4 |
| SBP (mm Hg) | 121.6 ± 15.5 |
| DBP (mm Hg) | 70.8 ± 10.5 |
| Left ventricular ejection fraction (%) | 66.6 ± 8.2 |
| Small pericardial effusion graded by echocardiography | 10 (13.7%) |
| Hemoglobin (g/dL) | 10.6 ± 1.3 |
| Serum creatinine (µmol/L) | 84.4 ± 49.1 |
| C-reactive protein (mg/L) | 60.9 ± 48.5 |
| Hypertension | 54.8% |
| Sinus rhythm | 93.1% |
| Smoking | 28.7% |
| Sedentary lifestyle | 23.3% |
| Surgical interventions | |
| <48 h delay from first symptom to surgery | 89% |
| Prosthetic Aortic tube | 98.6% |
| Aortic valve replacement | 26.0% |
| Baseline medications | |
| Anticoagulants | 39.7% |
| VKA | 35.6% |
| DOAC | 4.1% |
| Antiplatelet drugs without VKA | 38.3% |
| ß-blocker | 90.4% |
| ACEI/ARB | 63.0% |
| CCB | 40.3% |
| Diuretics | 23.3% |
| ≥3 Antihypertensive drugs | 60.3% |
Abbreviations: CR: cardiac rehabilitation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; DOAC: direct oral anticoagulants; VKA: vitamin K antagonist; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker (calcium antagonist). Values are mean ± SD.
Results of training in CR.
| Before CR | After CR | |
|---|---|---|
|
| ||
| Delay between surgery and CR (days) | 26.2 ± 17.3 | |
| Length of stay for phase II CR (days) | 30.4 ± 11.6 | |
| Sessions of continuous endurance training (times) | 14.5 ± 4.7 | |
| Sessions of segmental strength training (times) | 11.8 ± 4.3 | |
|
| ||
| Maximal SBP during endurance training (mm Hg) | 143 ± 14 | |
| Maximal DBP during endurance training (mm Hg) | 88 ± 14 | |
| Workload during endurance training (watts) | 27.1 ± 16.1 | 46.8 ± 21.2 *** |
| Gain of workload during endurance training (watts) | +19.6 ± 10.2 | |
|
| ||
| Resting HR during ExT (bpm) | 86.1 ± 17.4 | 76.4 ± 13.3 *** |
| Maximal HR during ExT (bpm) | 105.0 ± 22.8 | 110.6 ± 17.2 |
| HR reserve | 20.2 ± 13.9 | 33.2 ± 16.8 *** |
| Resting SBP | 115.3 ± 23.2 | 116.6 ± 24.8 |
| Resting DBP | 68.5 ± 13.2 | 69.4 ± 13.5 |
| Maximal SBP during ExT (mm Hg) | 142.1 ± 28.9 | 169.8 ± 39.0 * |
| Maximal DBP during ExT (mm Hg) | 74.7 ± 19.1 | 95.7 ± 30.2 ** |
| Maximal workload during ExT (watts) | 63.5 ± 28.6 | 93.0 ± 35.6 *** |
| Functional capacity (METs) | 3.67 ± 0.96 | 4.94 ± 1.21 *** |
| Gain of METs | +1.2 ± 0.6 | |
Abbreviations: CR: cardiac rehabilitation; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; METs: metabolic equivalents. Values are mean ± SD. *: p < 0.05, **: p < 0.01, ***: p < 0.001; before vs. after CR.
Correlation gain of exercise capacity after endurance training program.
| Correlation (r) | Baseline | Gain of Workload | Number of Training Session | Baseline | Gain of |
|---|---|---|---|---|---|
| Gain of METs after CR | −0.40 * | 0.55 * | 0.24 | −0.46 * | 0.6 * |
Abbreviations: CR: cardiac rehabilitation; METs: metabolic equivalents; DBP: diastolic blood pressure; HR: heart rate. *: p < 0.05.